Concepedia

Jason Valent

JV

Statistics

Publications

44

Citations

2.1K

H-Index

22

Active since

2010

Affiliations

Cleveland Clinic(Current)

The University of Texas Southwestern Medical Center

The University of Texas MD Anderson Cancer Center

City of Hope

Jason Valent is an author at Cleveland Clinic specializing in medicine, oncology, and multiple myeloma therapy.

ORCID

Publications per year

2010–2025

44

Publications

44

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2023 · 147 citations · Full text

, , +17

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

Saad Z. Usmani, Antje Hoering, Sikander Ailawadhi et al. · The Lancet Haematology · 2020 · 125 citations · Full text

, , +13

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

Vikram Premkumar, Suzanne Lentzsch, Samuel Pan et al. · Blood Cancer Journal · 2021 · 109 citations · Full text

, , +14

Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure

Brett W. Sperry, Asad Ikram, Rory Hachamovitch et al. · Journal of the American College of Cardiology · 2016 · 93 citations

, , +9

1–5 of 44